Salvage Treatment Improved Survival of Patients With Relapsed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 3, 2009, Pages 747-752

  Zhang, Xin xing ^a   Xie, Cong hua ^b   Xu, Yong ^a   Deng, Di ^b   Zhao, Yan hai ^c   Zou, Bing wen ^a   Zhou, Lin ^a   Li, Mei ^a   Wang, Jin ^a   Liu, Wei ping ^a   Huang, Mei juan ^a  

^a SICHUAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Extranodal NK T cell lymphoma; Retrospective analysis; Salvage treatment

Indexed keywords

ANN ARBORS; CLINICAL OUTCOME; COMPLETE RESPONSE; EXTRANODAL NK/T-CELL LYMPHOMA; INITIAL TREATMENT; NATURAL KILLER; OVERALL SURVIVAL RATES; RETROSPECTIVE ANALYSIS; SALVAGE TREATMENT; SIGNIFICANT FACTORS; T-CELL LYMPHOMAS; UNIVARIATE;

CHEMOTHERAPY;

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COLON DISEASE; COLONORRHAGIA; FEMALE; HEARING LOSS; HUMAN; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; NK T CELL LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; SALVAGE THERAPY; SEPSIS; SINUSITIS; SKIN ATROPHY; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE; XEROSTOMIA;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FEMALE; HUMANS; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; PREDNISONE; RADIOTHERAPY, CONFORMAL; RECURRENCE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 67049171164     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.08.066     Document Type: Article

References (24)

1. Jaffe E.S., Harris N.L., Stein H., et al., World Health Organization classification of tumours. Pathology and genetics of tumours of the hematopoietic and lymphoid tissues (2001), IARC Press, Lyon, France p. 204-207
2. Kim T.M., Park Y.H., Lee S.Y., et al. Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal type. Blood 106 (2005) 3785-3790
3. Yong W., Zheng W., Zhang Y., et al. L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma. Int J Hematol 78 (2003) 163-167
4. Isobe K., Uno T., Tamaru J., et al. Extranodal natural killer/T-cell lymphoma, nasal type: The significance of radiotherapeutic parameters. Cancer 106 (2006) 609-615
5. Lee J., Suh C., Park Y.H., et al. Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study. J Clin Oncol 24 (2006) 612-618
6. Cheung M.M., Chan J.K., Lau W.H., et al. Early stage nasal NK/T-cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 54 (2002) 182-190
7. Tham I.W., Lee K.M., Yap S.P., et al. Outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated with radiotherapy, with or without chemotherapy. Head Neck 28 (2006) 126-134
8. Huang M.J., Jiang Y., Liu W.P., et al. Early or upfront radiotherapy improved survival of localized extranodal NK/T lymphoma, nasal-type in the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 70 (2008) 166-174
9. Chen A.I., McMillan A., Negrin R.S., et al. Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: The Stanford experience. Biol Blood Marrow Transplant 14 (2008) 741-747
10. Li Y.X., Yao B., Jin J., et al. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol 24 (2006) 181-189
11. Koom W.S., Chung E.J., Yang W.I., et al. Angiocentric T-cell and NK/T-cell lymphomas: Radiotherapeutic viewpoints. Int J Radiat Oncol Biol Phys 59 (2004) 1127-1137
12. You J.Y., Chi K.H., Yang M.H., et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: A single institute survey in Taiwan. Ann Oncol 15 (2004) 618-625
13. Kristensen C.A., Kjaer-Kristoffersen F., Sapru W., et al. Nasopharyngeal carcinoma. Treatment planning with IMRT and 3D conformal radiotherapy. Acta Oncol 46 (2007) 214-220
14. Allen A.M., and Tishler R.B. Commentary: IMRT for head and neck cancer: Many chapters left to write. Oncologist 12 (2007) 565-568
15. Yamaguchi M., Kita K., Miwa H., et al. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer 76 (1995) 2351-2356
16. Fauci A.S., and Wolff S.M. Radiation therapy of midline granuloma. Ann Intern Med 84 (1976) 140-147
17. Campo E., Cardesa A., Alos L., et al. Non-Hodgkin's lymphomas of nasal cavity and paranasal sinuses: An immunohistochemical study. Am J Clin Pathol 96 (1991) 184-190
18. Chaudhary P.M., Mechetner E.B., and Roninson I.B. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80 (1992) 2735-2739
19. Nagafuji K., Fujisaki T., Arima F., et al. L-asparagine induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation. Int J Hematol 74 (2001) 447-450
20. Codegoni A.M., Biondi A., Conter V., et al. Human monocytic leukemia expresses low levels of asparagine synthase and is potentially sensitive to L-asparaginase. Leukemia 9 (1995) 360-361
21. Sherf U., Ross D.T., Waltthom M., et al. A gene expression data base for the molecular pharmacology of cancer. Nat Genet 24 (2000) 236-244
22. Yamaguchi M., Suzuki R., Kwong Y.L., et al. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 99 (2008) 1016-1020
23. Drénou B., Lamy T., Amiot L., et al. CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. Blood 89 (1997) 2966-2974
24. Bekkenk M.W., Jansen P.M., Meijer C.J.L.M., et al. CD56+ hematological neoplasms presenting in the skin: A retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 15 (2004) 1097-1108